Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paz

Showing results (561-570 of 577) with videos related to

Pageof 58
Sort By:
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2023
The polygenic basis of relapse after a first episode of schizophreniaÀlex-González Segura, Llucia Prohens, Patricia Gassó, et al.
Journal of the Neurological Sciences|September 14, 2020
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depressionD Santos-García, T de Deus Fonticoba, E Suárez Castro, et al.
Epidemiology and Psychiatric Sciences|November 17, 2020
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrumL-K Pries, G A Dal Ferro, J van Os, et al.
Parkinson'S Disease|June 7, 2021
Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of LifeD Santos García, T De Deus Fonticoba, J M Paz González, et al.
NPJ Parkinson'S Disease|December 17, 2021
Predictors of clinically significant quality of life impairment in Parkinson's diseaseDiego Santos García, Teresa de Deus Fonticoba, Carlos Cores, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 17, 2023
Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive ComplaintsDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Journal of Personalized Medicine|July 2, 2021
Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-UpDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Schizophrenia Research|October 11, 2025
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosisAlex G Segura, Norma Verdolini, Isabel Valli, et al.
Journal of Parkinson'S Disease|October 4, 2021
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control GroupDiego Santos García, Lucía García Roca, Teresa de Deus Fonticoba, et al.
Pageof 58

Showing results (561-570 of 577) with videos related to

Sort By:
Pageof 58
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2023
The polygenic basis of relapse after a first episode of schizophreniaÀlex-González Segura, Llucia Prohens, Patricia Gassó, et al.
Journal of the Neurological Sciences|September 14, 2020
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depressionD Santos-García, T de Deus Fonticoba, E Suárez Castro, et al.
Epidemiology and Psychiatric Sciences|November 17, 2020
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrumL-K Pries, G A Dal Ferro, J van Os, et al.
Parkinson'S Disease|June 7, 2021
Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of LifeD Santos García, T De Deus Fonticoba, J M Paz González, et al.
NPJ Parkinson'S Disease|December 17, 2021
Predictors of clinically significant quality of life impairment in Parkinson's diseaseDiego Santos García, Teresa de Deus Fonticoba, Carlos Cores, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 17, 2023
Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive ComplaintsDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Journal of Personalized Medicine|July 2, 2021
Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-UpDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Schizophrenia Research|October 11, 2025
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosisAlex G Segura, Norma Verdolini, Isabel Valli, et al.
Journal of Parkinson'S Disease|October 4, 2021
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control GroupDiego Santos García, Lucía García Roca, Teresa de Deus Fonticoba, et al.
Pageof 58